9 results
Chronic Obstructive Pulmonary Disease (COPD)
 • COPD Definition
 • Role of PFTs
 • COPD Classification and
PFTs • COPD Classification ... and Evaluation ... Disease #COPD #diagnosis ... #management #GOLD2022 ... #treatment
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary
 • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
(SLE) - Diagnosis ... Positive in 60-80% of cases ... life-threatening • Treatment ... of SLE • Evolution ... Erythematosus #Diagnosis
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
Discontinuation of causal ... life-threatening • Treatment ... Usual therapeutic management ... #rheumatology #diagnosis ... #management
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
+ Etiological Assessment ... for etiological assessment ... Treatment: • ... inhibitors under evaluation ... #management #treatment
Hemophilia - Diagnosis and Management
Diagnosis:
 • Consistent bleeding history (unless screening for disease in family members
and Management ... normal in mild cases ... Avoid meds that ... though safety assessment ... #Management #treatment
Aortic Dissection Pearls
Aortic dissection is caused by a tear in the tunica intima, the innermost layer
dissection is caused ... Evaluation: 1. ... deficit • Shock Treatment ... Aortic #Dissection #diagnosis ... #management #vascular
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
The assessment of ... are excellent at evaluating ... & Dry) is the treatment ... the determined cause ... #algorithm #management
Pulmonary Nodule
Evaluation is guided by nodule size & assessment of probability of malignancy. In addition is
Pulmonary Nodule Evaluation ... nodule size & assessment ... are called lung masses ... The treatment of ... Management options
Drug Induced Lupus (DIL)
 • Epidemiology: -10% of all lupus cases, drug-dependent, 4:1 to 1:1 F:M
constitutional symptoms • Treatment ... Discontinuation of causal ... cutaneous-DIL • Evolution ... #rheumatology #diagnosis ... #treatment #management